Cargando…
Long-Term Outcome and Complications of IOL-Exchange
PURPOSE: To describe the long-term outcome after intraocular lens (IOL) exchange for IOL-opacification with a focus on any occurring complications. PATIENTS AND METHODS: Patients with an IOL exchange for opacified IOLs (Lentis LS-502-1) were identified. Medical records and information from the treat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625384/ https://www.ncbi.nlm.nih.gov/pubmed/37927577 http://dx.doi.org/10.2147/OPTH.S436963 |
_version_ | 1785131121575460864 |
---|---|
author | Märker, David A Radeck, Viola Barth, Teresa Helbig, Horst Scherer, Nicolas C D |
author_facet | Märker, David A Radeck, Viola Barth, Teresa Helbig, Horst Scherer, Nicolas C D |
author_sort | Märker, David A |
collection | PubMed |
description | PURPOSE: To describe the long-term outcome after intraocular lens (IOL) exchange for IOL-opacification with a focus on any occurring complications. PATIENTS AND METHODS: Patients with an IOL exchange for opacified IOLs (Lentis LS-502-1) were identified. Medical records and information from the treating ophthalmologists were reviewed. Visual outcomes and any occurring complications after the IOL exchange were analyzed. RESULTS: IOL exchange was performed in 48 eyes of 46 patients and significantly improved best-corrected distance visual acuity from 0.42 ± 0.32 logMar (mean ± SD) in opacified lenses to 0.25 ± 0.28 logMar after IOL exchange. Nine of the 48 eyes (19%) underwent 11 further surgical procedures for complications due to four indications: IOL dislocation (n = 2, 4%), retinal detachment (RD) (n = 6, 12%), epiretinal membrane (n = 2, 4%), and pupillary block (n = 1, 2%). Three eyes (6%) developed a temporarily elevated intraocular pressure. Temporary postoperative cystoid macular edema was found in 2 eyes (4%). CONCLUSION: IOL exchange can restore vision owing to IOL opacification in most cases. Nonetheless, IOL exchange is not an easy or risk-free procedure. This may lead to sight-threatening complications, even in eyes without predisposing ocular comorbidities. |
format | Online Article Text |
id | pubmed-10625384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-106253842023-11-05 Long-Term Outcome and Complications of IOL-Exchange Märker, David A Radeck, Viola Barth, Teresa Helbig, Horst Scherer, Nicolas C D Clin Ophthalmol Original Research PURPOSE: To describe the long-term outcome after intraocular lens (IOL) exchange for IOL-opacification with a focus on any occurring complications. PATIENTS AND METHODS: Patients with an IOL exchange for opacified IOLs (Lentis LS-502-1) were identified. Medical records and information from the treating ophthalmologists were reviewed. Visual outcomes and any occurring complications after the IOL exchange were analyzed. RESULTS: IOL exchange was performed in 48 eyes of 46 patients and significantly improved best-corrected distance visual acuity from 0.42 ± 0.32 logMar (mean ± SD) in opacified lenses to 0.25 ± 0.28 logMar after IOL exchange. Nine of the 48 eyes (19%) underwent 11 further surgical procedures for complications due to four indications: IOL dislocation (n = 2, 4%), retinal detachment (RD) (n = 6, 12%), epiretinal membrane (n = 2, 4%), and pupillary block (n = 1, 2%). Three eyes (6%) developed a temporarily elevated intraocular pressure. Temporary postoperative cystoid macular edema was found in 2 eyes (4%). CONCLUSION: IOL exchange can restore vision owing to IOL opacification in most cases. Nonetheless, IOL exchange is not an easy or risk-free procedure. This may lead to sight-threatening complications, even in eyes without predisposing ocular comorbidities. Dove 2023-10-31 /pmc/articles/PMC10625384/ /pubmed/37927577 http://dx.doi.org/10.2147/OPTH.S436963 Text en © 2023 Märker et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Märker, David A Radeck, Viola Barth, Teresa Helbig, Horst Scherer, Nicolas C D Long-Term Outcome and Complications of IOL-Exchange |
title | Long-Term Outcome and Complications of IOL-Exchange |
title_full | Long-Term Outcome and Complications of IOL-Exchange |
title_fullStr | Long-Term Outcome and Complications of IOL-Exchange |
title_full_unstemmed | Long-Term Outcome and Complications of IOL-Exchange |
title_short | Long-Term Outcome and Complications of IOL-Exchange |
title_sort | long-term outcome and complications of iol-exchange |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625384/ https://www.ncbi.nlm.nih.gov/pubmed/37927577 http://dx.doi.org/10.2147/OPTH.S436963 |
work_keys_str_mv | AT markerdavida longtermoutcomeandcomplicationsofiolexchange AT radeckviola longtermoutcomeandcomplicationsofiolexchange AT barthteresa longtermoutcomeandcomplicationsofiolexchange AT helbighorst longtermoutcomeandcomplicationsofiolexchange AT scherernicolascd longtermoutcomeandcomplicationsofiolexchange |